Evidence-Based Medicine Guidelines
Rituximab as maintenance therapy for patients with follicular lymphoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rituximab as Maintenance Therapy for Patients With Follicular Lymphoma." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452527/all/Rituximab_as_maintenance_therapy_for_patients_with_follicular_lymphoma.
Rituximab as maintenance therapy for patients with follicular lymphoma. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/452527/all/Rituximab_as_maintenance_therapy_for_patients_with_follicular_lymphoma. Accessed March 28, 2025.
Rituximab as maintenance therapy for patients with follicular lymphoma. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/452527/all/Rituximab_as_maintenance_therapy_for_patients_with_follicular_lymphoma
Rituximab as Maintenance Therapy for Patients With Follicular Lymphoma [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452527/all/Rituximab_as_maintenance_therapy_for_patients_with_follicular_lymphoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rituximab as maintenance therapy for patients with follicular lymphoma
ID - 452527
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452527/all/Rituximab_as_maintenance_therapy_for_patients_with_follicular_lymphoma
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
